سعر بيرونتاجونيست 10مجم 20 قرص 2024

Montelukast 10 mg film-coated tablets, pack of 20 (EGPI / Advance Pharma, Egypt).

• Prophylaxis and chronic treatment of asthma (10 mg tablet for patients 15 years and older).DailyMed (U.S. National Library of Medicine)
• Prevention of exercise-induced bronchoconstriction; relief of allergic rhinitis symptoms when alternative therapies are inadequate or not tolerated.DailyMed (U.S. National Library of Medicine)

• Most common adverse reactions (>=5% and greater than placebo) in trials: upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhoea, otitis media, influenza, rhinorrhoea.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Hypersensitivity to any component.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: serious neuropsychiatric events (agitation, aggression, depression, sleep disturbances, suicidal thoughts and behaviour) have been reported; reserve for allergic rhinitis when alternatives are inadequate.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Not for treatment of an acute asthma attack; do not abruptly substitute for inhaled or oral corticosteroids.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Cohort data over decades have not established a drug-associated risk of major birth defects.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Montelukast is present in human milk; available data do not suggest a significant risk of adverse reactions in the breastfed infant.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Montelukast: Orally active, selective antagonist of the cysteinyl leukotriene type-1 (CysLT1) receptor, blocking LTD4-mediated airway oedema, smooth-muscle contraction and inflammation (SINGULAIR US label).